Revenue (Tables)

9 Months Ended

Sep. 27, 2024

Revenue from Contract with Customer [Abstract]

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 27, 2024 and September 29, 2023 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Total
For the Three-Month Period Ended September 27, 2024:
Geographical region:
North America(a)	$	503	$	796	$	1,157	$	2,456
Western Europe	587		365		368		1,320
Other developed markets(b)	78		120		101		299
High-growth markets(c)	485		501		737		1,723
Total	$	1,653	$	1,782	$	2,363	$	5,798

Revenue type:
Recurring	$	1,422	$	1,228	$	2,127	$	4,777
Nonrecurring	231		554		236		1,021
Total	$	1,653	$	1,782	$	2,363	$	5,798

For the Three-Month Period Ended September 29, 2023:
Geographical region:
North America(a)	$	593	$	728	$	1,054	$	2,375
Western Europe	508		356		334		1,198
Other developed markets(b)	78		117		105		300
High-growth markets(c)	485		505		761		1,751
Total	$	1,664	$	1,706	$	2,254	$	5,624

Revenue type:
Recurring	$	1,390	$	1,062	$	1,986	$	4,438
Nonrecurring	274		644		268		1,186
Total	$	1,664	$	1,706	$	2,254	$	5,624


	Biotechnology		Life Sciences		Diagnostics		Total
For the Nine-Month Period Ended September 27, 2024:
Geographical region:
North America(a)	$	1,624	$	2,362	$	3,536	$	7,522
Western Europe	1,700		1,111		1,154		3,965
Other developed markets(b)	238		361		295		894
High-growth markets(c)	1,328		1,463		2,165		4,956
Total	$	4,890	$	5,297	$	7,150	$	17,337

Revenue type:
Recurring	$	4,209	$	3,628	$	6,424	$	14,261
Nonrecurring	681		1,669		726		3,076
Total	$	4,890	$	5,297	$	7,150	$	17,337

For the Nine-Month Period Ended September 29, 2023:
Geographical region:
North America(a)	$	1,822	$	2,193	$	3,160	$	7,175
Western Europe	1,839		1,095		1,119		4,053
Other developed markets(b)	229		369		322		920
High-growth markets(c)	1,523		1,554		2,260		5,337
Total	$	5,413	$	5,211	$	6,861	$	17,485

Revenue type:
Recurring	$	4,435	$	3,205	$	6,056	$	13,696
Nonrecurring	978		2,006		805		3,789
Total	$	5,413	$	5,211	$	6,861	$	17,485

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets.

(c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.